• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚甲基丙烯酸甲酯(PMMA)与透明质酸(HA)填充物栓塞风险比较。

Risk Comparison of Filler Embolism Between Polymethyl Methacrylate (PMMA) and Hyaluronic Acid (HA).

机构信息

Department of Plastic Surgery, Peking University Third Hospital, 49 North Garden Rd., Haidian District, Beijing, 100191, People's Republic of China.

出版信息

Aesthetic Plast Surg. 2019 Jun;43(3):853-860. doi: 10.1007/s00266-019-01320-w. Epub 2019 Mar 1.

DOI:10.1007/s00266-019-01320-w
PMID:30824948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6522461/
Abstract

BACKGROUND

The incidence of vascular complications varies among different fillers. The main purpose of this study was to compare the risk of embolism between PMMA (Artecoll) and hyaluronic acid (HA, Restylane) after artery injection.

METHODS

Rabbit ears were injected via the central artery with 0.1 ml PMMA (group A), 0.1 ml HA (group B), 0.2 ml PMMA (group C), or 0.2 mL HA (group D), respectively. The formation of transparent emboli was monitored right after injection. Tissue necrosis and histopathological changes were analyzed on day 7.

RESULTS

With 0.1 ml injected volume, PMMA was dispersed within a few minutes and only 5% of the injected ears had mild necrosis on day 7, while HA tended to form obvious transparent emboli, an indication of blood vessel clotting, and 60% of injected ears showed necrosis on day 7. With 0.2 ml injected volume, PMMA had a risk of complete blood vessel clotting in between 0.1 ml PMMA group and 0.1 ml HA group, and 30% of injected ears had necrosis; in contrast, 100% of 0.2 ml HA-injected ears showed transparent emboli and necrosis. The necrosis areas were significantly increased in the HA groups compared with PMMA groups at the same injection volumes. HA injection also caused dilation of small blood vessels.

CONCLUSION

At the same injection volume, PMMA had less risk of embolism compared with HA. With increased injection volume, there were increased risks of embolism and necrosis for both PMMA and HA.

NO LEVEL ASSIGNED

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

摘要

背景

不同填充物的血管并发症发生率不同。本研究的主要目的是比较动脉内注射后 PMMA(Artecoll)和透明质酸(HA,Restylane)发生栓塞的风险。

方法

通过中央动脉分别向兔耳内注射 0.1ml PMMA(A 组)、0.1mlHA(B 组)、0.2mlPMMA(C 组)或 0.2mlHA(D 组)。注射后立即监测透明栓塞的形成。第 7 天分析组织坏死和组织病理学变化。

结果

注射 0.1ml 体积时,PMMA 在数分钟内分散,仅 5%的注射耳在第 7 天出现轻度坏死,而 HA 则倾向于形成明显的透明栓塞,表明血管内凝血,60%的注射耳在第 7 天出现坏死。注射 0.2ml 体积时,PMMA 在 0.1mlPMMA 组和 0.1mlHA 组之间有完全血管内凝血的风险,30%的注射耳出现坏死;相比之下,100%的 0.2mlHA 注射耳出现透明栓塞和坏死。在相同的注射量下,HA 组的坏死面积明显大于 PMMA 组。HA 注射还导致小血管扩张。

结论

在相同的注射量下,PMMA 发生栓塞的风险低于 HA。随着注射量的增加,PMMA 和 HA 发生栓塞和坏死的风险均增加。

未分级

本杂志要求作者为每篇文章指定一个证据水平。有关这些循证医学评级的完整描述,请参考目录或在线作者指南 www.springer.com/00266 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/a470124d6f7a/266_2019_1320_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/f033d2283ef7/266_2019_1320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/0a67ce8dfe77/266_2019_1320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/425655c1069a/266_2019_1320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/1fa349ca4929/266_2019_1320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/5edb7cd84702/266_2019_1320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/292c1b3940d9/266_2019_1320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/092c6bb1017e/266_2019_1320_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/8f02a228335d/266_2019_1320_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/4294bef228f3/266_2019_1320_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/a470124d6f7a/266_2019_1320_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/f033d2283ef7/266_2019_1320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/0a67ce8dfe77/266_2019_1320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/425655c1069a/266_2019_1320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/1fa349ca4929/266_2019_1320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/5edb7cd84702/266_2019_1320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/292c1b3940d9/266_2019_1320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/092c6bb1017e/266_2019_1320_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/8f02a228335d/266_2019_1320_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/4294bef228f3/266_2019_1320_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/6522461/a470124d6f7a/266_2019_1320_Fig10_HTML.jpg

相似文献

1
Risk Comparison of Filler Embolism Between Polymethyl Methacrylate (PMMA) and Hyaluronic Acid (HA).聚甲基丙烯酸甲酯(PMMA)与透明质酸(HA)填充物栓塞风险比较。
Aesthetic Plast Surg. 2019 Jun;43(3):853-860. doi: 10.1007/s00266-019-01320-w. Epub 2019 Mar 1.
2
The Role of Hyaluronidase for the Skin Necrosis Caused by Hyaluronic Acid Injection-Induced Embolism: A Rabbit Auricular Model Study.透明质酸注射致栓塞引起皮肤坏死的透明质酸酶作用:兔耳模型研究。
Aesthetic Plast Surg. 2019 Oct;43(5):1362-1370. doi: 10.1007/s00266-019-01398-2. Epub 2019 May 28.
3
An Islanded Rabbit Auricular Skin Flap Model of Hyaluronic Acid Injection-Induced Embolism.透明质酸注射诱导栓塞的岛状兔耳皮肤瓣模型
Aesthetic Plast Surg. 2016 Jun;40(3):421-7. doi: 10.1007/s00266-016-0630-0. Epub 2016 Apr 26.
4
Clinical Observations and the Anatomical Basis of Blindness After Facial Hyaluronic Acid Injection.面部透明质酸注射后失明的临床观察及解剖学基础
Aesthetic Plast Surg. 2019 Aug;43(4):1054-1060. doi: 10.1007/s00266-019-01374-w. Epub 2019 Apr 21.
5
Percutaneous Intra-arterial Hyaluronidase Injection for Hyaluronic Acid Filler Embolism Threatening Skin Barrier Integrity: Implementation of a Stepwise Treatment Protocol.经皮动脉内透明质酸酶注射治疗威胁皮肤屏障完整性的透明质酸填充物栓塞:逐步治疗方案的实施。
Aesthetic Plast Surg. 2024 Feb;48(4):747-751. doi: 10.1007/s00266-023-03640-4. Epub 2023 Sep 29.
6
Efficacy of Superselective Intra-arterial Recanalization of Embolized Arteries Resulting from Facial Hyaluronic Acid Injection.经皮腔内血管成形术治疗面部注射透明质酸后栓塞动脉的疗效。
Aesthetic Plast Surg. 2024 Sep;48(18):3561-3567. doi: 10.1007/s00266-024-04004-2. Epub 2024 May 8.
7
Efficacy and Safety of Lyophilized Articular Cartilage Matrix as an Injectable Facial Filler.冻干关节软骨基质作为注射用面部填充物的疗效和安全性。
Aesthetic Plast Surg. 2021 Jun;45(3):1266-1272. doi: 10.1007/s00266-020-02017-1. Epub 2020 Nov 20.
8
Vascular Complications After Chin Augmentation Using Hyaluronic Acid.使用透明质酸隆颏后的血管并发症
Aesthetic Plast Surg. 2018 Apr;42(2):553-559. doi: 10.1007/s00266-017-1036-3. Epub 2017 Dec 19.
9
Hyaluronic Acid Dermal Filler Promotes Cartilage Reshaping in Rabbit Ears.透明质酸真皮填充剂促进兔耳软骨重塑。
Aesthetic Plast Surg. 2022 Aug;46(4):1932-1941. doi: 10.1007/s00266-022-02873-z. Epub 2022 Apr 1.
10
Exploring the Possibility of a Retrograde Embolism Pathway from the Facial Artery to the Ophthalmic Artery System In Vivo.探索面动脉至眼动脉系统逆行性栓塞途径在体内的可能性。
Aesthetic Plast Surg. 2017 Oct;41(5):1222-1227. doi: 10.1007/s00266-017-0877-0. Epub 2017 Apr 21.

引用本文的文献

1
A new protocol (THIS and FAT) for the treatment of filler-induced vascular occlusion: a case series.一种治疗填充剂所致血管阻塞的新方案(THIS和FAT):病例系列
Front Med (Lausanne). 2025 Jul 30;12:1585983. doi: 10.3389/fmed.2025.1585983. eCollection 2025.
2
In Vivo Evaluation of the Anti-Skin-Ageing Bioactivity of a Recombinant Dual Humanised Collagen and Poly-L-Lactic Acid.重组双人源化胶原蛋白和聚-L-乳酸抗皮肤衰老生物活性的体内评估
Bioengineering (Basel). 2025 May 12;12(5):510. doi: 10.3390/bioengineering12050510.
3
Arterioembolic Characteristics of Differentially Diluted CaHA-CMC Gels Within An Artificial Macrovascular Perfusion Model.

本文引用的文献

1
Biochemistry, Physiology, and Tissue Interactions of Contemporary Biodegradable Injectable Dermal Fillers.当代可生物降解注射用真皮填充剂的生物化学、生理学及组织相互作用
Dermatol Surg. 2018 Nov;44 Suppl 1:S19-S31. doi: 10.1097/DSS.0000000000001582.
2
Pathophysiology Study of Filler-Induced Blindness.填充物致盲的病理生理学研究。
Aesthet Surg J. 2019 Jan 1;39(1):96-106. doi: 10.1093/asj/sjy141.
3
Optimizing outcomes with polymethylmethacrylate fillers.使用聚甲基丙烯酸甲酯填充剂优化治疗效果。
人工大血管灌注模型中不同稀释度的羟基磷灰石-羧甲基纤维素凝胶的动脉栓塞特性
Aesthet Surg J. 2025 May 15;45(6):645-653. doi: 10.1093/asj/sjaf028.
4
Development of a Short-Term Embolic Agent Based on Cilastatin for Articular Microvessels.基于克拉维酸的短期栓塞剂在关节微血管中的应用。
Medicina (Kaunas). 2024 Sep 20;60(9):1538. doi: 10.3390/medicina60091538.
5
The Impact of Gel Parameters on the Dispersal and Fragmentation of Hyaluronic Acid Gel Fillers within an Artificial Model of Arterial Embolism.凝胶参数对透明质酸凝胶填充剂在动脉栓塞人工模型中的扩散和破碎的影响
Gels. 2024 Aug 12;10(8):530. doi: 10.3390/gels10080530.
6
In Vivo Models for the Study of Hyaluronic Acid Fillers: A Review.体内模型在透明质酸填充剂研究中的应用:综述。
Aesthetic Plast Surg. 2023 Jun;47(3):1185-1191. doi: 10.1007/s00266-022-03212-y. Epub 2023 Jan 3.
7
Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)-Implications for Therapeutic Interventions.百年难题的破解:透明质酸填充剂诱导血管闭塞(FIVO)的病理生理学和分子机制——对治疗干预的启示。
Molecules. 2022 Aug 24;27(17):5398. doi: 10.3390/molecules27175398.
8
PMMA-collagen Gel in Nonsurgical Rhinoplasty Defects: A Methodological Overview and 15-year Experience.聚甲基丙烯酸甲酯-胶原蛋白凝胶用于非手术隆鼻缺陷修复:方法概述及15年经验
Plast Reconstr Surg Glob Open. 2022 Aug 19;10(8):e4477. doi: 10.1097/GOX.0000000000004477. eCollection 2022 Aug.
J Cosmet Dermatol. 2018 Jun;17(3):298-304. doi: 10.1111/jocd.12539. Epub 2018 Mar 30.
4
Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations.软组织填充剂并发症的治疗:专家共识推荐
Aesthetic Plast Surg. 2018 Apr;42(2):498-510. doi: 10.1007/s00266-017-1063-0. Epub 2018 Jan 5.
5
A Cross-sectional Analysis of Adverse Events and Litigation for Injectable Fillers.注射用填充剂不良事件和诉讼的横断面分析。
JAMA Facial Plast Surg. 2018 May 1;20(3):207-214. doi: 10.1001/jamafacial.2017.1888.
6
Vascular Complications After Chin Augmentation Using Hyaluronic Acid.使用透明质酸隆颏后的血管并发症
Aesthetic Plast Surg. 2018 Apr;42(2):553-559. doi: 10.1007/s00266-017-1036-3. Epub 2017 Dec 19.
7
Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women.中国女性使用永久性真皮填充剂(爱贝芙-4)进行面部容积恢复。
Facial Plast Surg. 2017 Oct;33(5):537-544. doi: 10.1055/s-0037-1605599. Epub 2017 Sep 29.
8
Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers-Evidence- and Opinion-Based Review and Consensus Recommendations.全球美学共识:透明质酸填充剂并发症的预防与处理——基于证据和观点的综述及共识建议
Plast Reconstr Surg. 2016 Jun;137(6):961e-971e. doi: 10.1097/PRS.0000000000002184.
9
Avoiding and Treating Blindness From Fillers: A Review of the World Literature.避免和治疗填充剂导致的失明:世界文献综述
Dermatol Surg. 2015 Oct;41(10):1097-117. doi: 10.1097/DSS.0000000000000486.
10
Comparison of Artecoll, Restylane and silicone for augmentation rhinoplasty in 378 Chinese patients.
Clin Invest Med. 2014 Aug 1;37(4):E203-10. doi: 10.25011/cim.v37i4.21725.